question
stringlengths 18
168
| answer
stringlengths 1
209
⌀ |
|---|---|
Which is the most common cause of sudden cardiac death in young athletes? | hypertrophic cardiomyopathy |
Which is the most common cause of sudden cardiac death in young athletes? | Hypertrophic cardiomyopathy |
Which is the most common cause of sudden cardiac death in young athletes? | hypertrophic cardiomyopathy |
Which is the most common cause of sudden cardiac death in young athletes? | Hypertrophic cardiomyopathy |
Which is the most common cause of sudden cardiac death in young athletes? | Hypertrophic cardiomyopathy |
Mutation of which gene is associated with Achondroplasia? | fibroblast growth factor receptor 3 (FGFR3) |
Mutation of which gene is associated with Achondroplasia? | fibroblast growth factor receptor 3 (FGFR3) |
Mutation of which gene is associated with Achondroplasia? | fibroblast growth factor receptor 3 (FGFR3) |
Which drug is benserazide usually co-administered with? | l-DOPA |
Which drug is benserazide usually co-administered with? | L-Dopa |
Which drug is benserazide usually co-administered with? | l-DOPA |
Which drug is benserazide usually co-administered with? | l-DOPA |
Which drug is benserazide usually co-administered with? | L-DOPA |
Which drug is benserazide usually co-administered with? | L-DOPA |
Which drug is benserazide usually co-administered with? | L-DOPA |
Which drug is benserazide usually co-administered with? | L-DOPA |
Which drug is benserazide usually co-administered with? | L-DOPA |
Which drug is benserazide usually co-administered with? | L-DOPA |
Which drug is benserazide usually co-administered with? | L-DOPA |
Which drug is benserazide usually co-administered with? | L-DOPA |
Which drug is benserazide usually co-administered with? | L-Dopa |
Which drug is benserazide usually co-administered with? | L-Dopa |
Which drug is benserazide usually co-administered with? | L-dopa |
Which drug is benserazide usually co-administered with? | L-dopa |
Which drug is benserazide usually co-administered with? | l-DOPA |
Which drug is benserazide usually co-administered with? | L-dopa |
Which drug is benserazide usually co-administered with? | L-dopa |
Which drug is benserazide usually co-administered with? | l-DOPA |
Which drug is benserazide usually co-administered with? | L-dopa |
Which drug is benserazide usually co-administered with? | L-dopa |
Which drug is benserazide usually co-administered with? | L-dopa |
Which drug is benserazide usually co-administered with? | L-dopa |
Which drug is benserazide usually co-administered with? | L-dopa |
Which drug is benserazide usually co-administered with? | L-dopa |
Inhibition of which transporter is the mechanism of action of drug Canagliflozin? | Sodium glucose co-transporter 2 |
Inhibition of which transporter is the mechanism of action of drug Canagliflozin? | sodium glucose co-transporter 2 |
Which glands are subject to attack by lymphocytes in Sjogren's syndrome? | the lacrimal and/or salivary glands |
What is the incidence of Edwards syndrom in the european population? | 1:5000 |
Which thyroid hormone transporter is implicated in thyroid hormone resistance syndrome? | MCT8 |
Which thyroid hormone transporter is implicated in thyroid hormone resistance syndrome? | MCT8 |
Which thyroid hormone transporter is implicated in thyroid hormone resistance syndrome? | MCT8 |
Which thyroid hormone transporter is implicated in thyroid hormone resistance syndrome? | MCT8 |
What is the life expectancy of professional athletes in respect to the general population? | longer than the general population |
What disease in Loxapine prominently used for? | schizophrenia |
What disease in Loxapine prominently used for? | schizophrenia |
What disease in Loxapine prominently used for? | schizophrenia |
What disease in Loxapine prominently used for? | schizophrenia |
What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)? | autosomal dominant |
What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)? | autosomal dominant |
What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)? | autosomal dominant |
What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)? | autosomal dominant |
What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)? | autosomal dominant |
What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)? | autosomal dominant |
What is the usual HER-2 status in breast cancer associated with Li-Fraumeni syndrome? | positive |
What is the usual HER-2 status in breast cancer associated with Li-Fraumeni syndrome? | positive |
What is the usual HER-2 status in breast cancer associated with Li-Fraumeni syndrome? | positive |
What is the usual HER-2 status in breast cancer associated with Li-Fraumeni syndrome? | positive |
What is the usual HER-2 status in breast cancer associated with Li-Fraumeni syndrome? | positive |
What is the usual HER-2 status in breast cancer associated with Li-Fraumeni syndrome? | positive |
What is the usual HER-2 status in breast cancer associated with Li-Fraumeni syndrome? | positive |
What is the most probable defect underlying triple negative breast cancer? | BRCA1 dysfunction |
What is the mode of inheritance of Facioscapulohumeral muscular
dystrophy (FSHD)? | autosomal dominant |
Which is the molecular target of the immunosuppressant drug Rapamycin? | mTOR |
Which is the molecular target of the immunosuppressant drug Rapamycin? | mTOR |
Which is the molecular target of the immunosuppressant drug Rapamycin? | mTOR |
Which is the molecular target of the immunosuppressant drug Rapamycin? | mTOR |
Which is the molecular target of the immunosuppressant drug Rapamycin? | mTOR |
Which is the molecular target of the immunosuppressant drug Rapamycin? | mTOR |
Which is the molecular target of the immunosuppressant drug Rapamycin? | mTOR |
Which is the molecular target of the immunosuppressant drug Rapamycin? | mTOR |
Which is the molecular target of the immunosuppressant drug Rapamycin? | mTOR |
Which is the molecular target of the immunosuppressant drug Rapamycin? | mTOR |
Which is the molecular target of the immunosuppressant drug Rapamycin? | mTOR |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |
Mutation of which gene is associated with McLeod syndrome? | XK |